Consolidated Statements of Income - USD ($) shares in Millions, $ in Millions	3 Months Ended			9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014		Sep. 30, 2015	Sep. 30, 2014
Net Sales	$ 12,036	$ 14,405		$ 37,316	$ 43,783
Cost of sales	9,349	11,776		29,030	35,853
Research and development expenses	382	409		1,194	1,219
Selling, general and administrative expenses	689	753		2,214	2,283
Amortization of intangibles	105	108		316	330
Restructuring charges	0	0		375	0
Equity in earnings of nonconsolidated affiliates	135	229		575	707
Sundry income (expense) - net	632	(23)		1,680	31
Interest income	18	10		46	32
Interest expense and amortization of debt discount	233	233		706	721
Income Before Income Taxes	2,063	1,342		5,782	4,147
Provision for income taxes	627	378		1,630	1,147
Net Income	1,436	964		4,152	3,000
Net income attributable to noncontrolling interests	61	27		79	47
Net Income Attributable to The Dow Chemical Company	1,375	937		4,073	2,953
Preferred stock dividends	85	85	[1]	255	255	[1]
Net Income Available for The Dow Chemical Company Common Stockholders	$ 1,290	$ 852		$ 3,818	$ 2,698
Per Common Share Data:
Earnings per common share - basic	$ 1.12	$ 0.72		$ 3.33	$ 2.27
Earnings per common share - diluted	1.09	0.71		3.24	2.24
Dividends declared per share of common stock	$ 0.42	$ 0.37		$ 1.26	$ 1.11
Weighted-average common shares outstanding - basic	1,141.3	1,167.2		1,138.4	1,178.9
Weighted-average common shares outstanding - diluted	1,250.6	1,184.1		1,248.9	1,195.7
Depreciation	$ 494	$ 550		$ 1,463	$ 1,592
Capital Expenditures	$ 916	$ 930		$ 2,817	$ 2,466

[1] Preferred stock dividends were not added back in the calculation of diluted earnings per share for the three- and nine-month periods ended September 30, 2014, because the effect of adding them back would have been antidilutive.